文章基本信息

标题：Tunneling Nanotubes Mediate Adaptation of Glioblastoma Cells to Temozolomide and Ionizing Radiation Treatment
本地全文：下载
作者：Silvana Valdebenito ; Alessandra Audia ; Krishna P.L. Bhat 等
期刊名称：iScience
印刷版ISSN：2589-0042
出版年度：2020
卷号：23
期号：9
页码：1-32
DOI：10.1016/j.isci.2020.101450
语种：English
出版社：Elsevier
摘要：SummaryGlioblastoma (GBM) is the most prevalent and aggressive tumor in the central nervous system. Surgical resection followed by concurrent radiotherapy (ionizing radiation [IR]) and temozolomide (TMZ) is the standard of care for GBM. However, a large subset of patients offer resistance or become adapted to TMZ due mainly to the DNA repair enzyme O6-methylguanine-DNA methyltransferase (MGMT). Thus, alternative mechanisms of MGMT deregulation have been proposed but are heretofore unproven. We show that heterogeneous GBM cells express tunneling nanotubes (TNTs) upon oxidative stress and TMZ/IR treatment. We identified that MGMT protein diffused from resistant to sensitive cells upon exposure to TMZ/IR, resulting in protection against cytotoxic therapy in a TNT-dependent manner.In vivoanalysis of resected GBM tumors support our hypothesis that the MGMT protein, but not its mRNA, was associated with TNT biomarkers. We propose that targeting TNT formation could be an innovative strategy to overcome treatment resistance in GBM.Graphical AbstractDisplay OmittedHighlights•GBM cells form TNTs in response to ionizing radiation and TMZ treatment•TNTs transfer MGMT protein from resistant to sensitive cells to treatment•MGMT protein transferred via TNTs protect target cells from TMZ and IR treatment•Blocking TNTs and MGMT spread could prevent tumor adaptation to TMZ treatmentCell Biology; Cancer